Published on EmpowHER - Women's Health Online (https://www.empowher.com)

Home > Breaking News: FDA Panel Recommends Approval of Rivaroxaban (Xarelto) for Atrial Fibrillation Stroke Prevention

Breaking News: FDA Panel Recommends Approval of Rivaroxaban (Xarelto) for Atrial Fibrillation Stroke Prevention

By Mellanie True Hills
Created 09/10/2011 - 11:05

The US Food & Drug Administration (FDA) Advisory Committee just voted 9-2, with 1 abstaining, to recommend that the FDA approve rivaroxaban (Xarelto) for prevention of atrial fibrillation strokes. See our full story, now up at:

FDA Panel Votes for Rivaroxaban: Atrial Fibrillation Patients May Soon Have Two Alternatives to Warfarin for Stroke Prevention
http://bit.ly/r8bbWI

Copyright © 2024 HW, LLC d/b/a EmpowHER Media unless otherwise noted. EmpowHER does not provide medical advice, diagnosis, or treatment.
Source URL (retrieved on 04/19/2024 - 19:38): https://www.empowher.com/community/share/breaking-news-fda-panel-recommends-approval-rivaroxaban-xarelto-atrial-fibrillation-